ASX - By Stock
|
MSB |
Lower back pain trial
|
|
timmyjuly
|
4 |
2.4K |
10 |
23/03/24 |
23/03/24 |
ASX - By Stock
|
4
|
2.4K
|
10
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Grants Orphan Drug Designation for Revascor
|
|
timmyjuly
|
272 |
98K |
24 |
25/02/24 |
25/02/24 |
ASX - By Stock
|
272
|
98K
|
24
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Completes Institutional Allocation
|
|
timmyjuly
|
263 |
67K |
10 |
05/12/23 |
05/12/23 |
ASX - By Stock
|
263
|
67K
|
10
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
timmyjuly
|
17K |
6.6M |
3 |
14/11/23 |
14/11/23 |
ASX - By Stock
|
17K
|
6.6M
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
timmyjuly
|
17K |
6.6M |
5 |
14/11/23 |
14/11/23 |
ASX - By Stock
|
17K
|
6.6M
|
5
|
|
ASX - By Stock
|
MSB |
Re:
CEO Itescu needs to go
|
|
timmyjuly
|
904 |
275K |
1 |
10/08/23 |
10/08/23 |
ASX - By Stock
|
904
|
275K
|
1
|
|
ASX - By Stock
|
MSB |
BLA resubmission timelines
|
|
timmyjuly
|
12 |
4.1K |
31 |
20/02/23 |
20/02/23 |
ASX - By Stock
|
12
|
4.1K
|
31
|
|
ASX - By Stock
|
MSB |
DREAM HF Trial Video
|
|
timmyjuly
|
99 |
33K |
89 |
02/02/23 |
02/02/23 |
ASX - By Stock
|
99
|
33K
|
89
|
|
ASX - By Stock
|
MSB |
Re:
GVHD the first step
|
|
timmyjuly
|
239 |
65K |
3 |
20/12/22 |
20/12/22 |
ASX - By Stock
|
239
|
65K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Long-Term Survival for Acute GvHD Treatment with Remestemcel
|
|
timmyjuly
|
355 |
95K |
5 |
27/11/22 |
27/11/22 |
ASX - By Stock
|
355
|
95K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Long-Term Survival for Acute GvHD Treatment with Remestemcel
|
|
timmyjuly
|
355 |
95K |
4 |
26/11/22 |
26/11/22 |
ASX - By Stock
|
355
|
95K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Long-Term Survival for Acute GvHD Treatment with Remestemcel
|
|
timmyjuly
|
355 |
95K |
1 |
25/11/22 |
25/11/22 |
ASX - By Stock
|
355
|
95K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Long-Term Survival for Acute GvHD Treatment with Remestemcel
|
|
timmyjuly
|
355 |
95K |
6 |
25/11/22 |
25/11/22 |
ASX - By Stock
|
355
|
95K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Long-Term Survival for Acute GvHD Treatment with Remestemcel
|
|
timmyjuly
|
355 |
95K |
4 |
25/11/22 |
25/11/22 |
ASX - By Stock
|
355
|
95K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Long-Term Survival for Acute GvHD Treatment with Remestemcel
|
|
timmyjuly
|
355 |
95K |
5 |
25/11/22 |
25/11/22 |
ASX - By Stock
|
355
|
95K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Long-Term Survival for Acute GvHD Treatment with Remestemcel
|
|
timmyjuly
|
355 |
95K |
1 |
25/11/22 |
25/11/22 |
ASX - By Stock
|
355
|
95K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Long-Term Survival for Acute GvHD Treatment with Remestemcel
|
|
timmyjuly
|
355 |
95K |
18 |
24/11/22 |
24/11/22 |
ASX - By Stock
|
355
|
95K
|
18
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
timmyjuly
|
9.4K |
2.7M |
3 |
28/09/22 |
28/09/22 |
ASX - By Stock
|
9.4K
|
2.7M
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Mesoblast in Freefall
|
|
timmyjuly
|
982 |
281K |
5 |
16/06/22 |
16/06/22 |
ASX - By Stock
|
982
|
281K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Chronic Lower Back Pain - the sleeping giant.
|
|
timmyjuly
|
484 |
146K |
3 |
14/06/22 |
14/06/22 |
ASX - By Stock
|
484
|
146K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Grunenthal (MSB's back partner) survey into degenerative disc disease
|
|
timmyjuly
|
5 |
1.7K |
10 |
21/12/21 |
21/12/21 |
ASX - By Stock
|
5
|
1.7K
|
10
|
|
ASX - By Stock
|
MSB |
Grunenthal (MSB's back partner) survey into degenerative disc disease
|
|
timmyjuly
|
5 |
1.7K |
10 |
21/12/21 |
21/12/21 |
ASX - By Stock
|
5
|
1.7K
|
10
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading 2021 - paradigm shift
|
|
timmyjuly
|
10K |
3.0M |
2 |
17/12/21 |
17/12/21 |
ASX - By Stock
|
10K
|
3.0M
|
2
|
|
ASX - By Stock
|
MSB |
Manufacturing
|
|
timmyjuly
|
4 |
1.0K |
15 |
18/10/21 |
18/10/21 |
ASX - By Stock
|
4
|
1.0K
|
15
|
|
ASX - By Stock
|
MSB |
The PBS willing to subsidise expensive therapies
|
|
timmyjuly
|
0 |
390 |
4 |
23/06/21 |
23/06/21 |
ASX - By Stock
|
0
|
390
|
4
|
|
ASX - By Stock
|
MSB |
CDC to hold ‘emergency meeting’ over cases of heart inflammation following second Covid vaccine
|
|
timmyjuly
|
3 |
1.9K |
8 |
13/06/21 |
13/06/21 |
ASX - By Stock
|
3
|
1.9K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Clinical trials.gov update
|
|
timmyjuly
|
44 |
29K |
4 |
07/10/20 |
07/10/20 |
ASX - By Stock
|
44
|
29K
|
4
|
|
ASX - By Stock
|
BRN |
Re:
2020 BRN Discussion
|
|
timmyjuly
|
29K |
13M |
2 |
21/09/20 |
21/09/20 |
ASX - By Stock
|
29K
|
13M
|
2
|
|
ASX - By Stock
|
BRN |
Re:
2020 BRN Discussion
|
|
timmyjuly
|
29K |
13M |
1 |
21/09/20 |
21/09/20 |
ASX - By Stock
|
29K
|
13M
|
1
|
|
ASX - By Stock
|
BRN |
Re:
2020 BRN Discussion
|
|
timmyjuly
|
29K |
13M |
3 |
21/09/20 |
21/09/20 |
ASX - By Stock
|
29K
|
13M
|
3
|
|
ASX - By Stock
|
BRN |
Re:
2020 BRN Discussion
|
|
timmyjuly
|
29K |
13M |
3 |
21/09/20 |
21/09/20 |
ASX - By Stock
|
29K
|
13M
|
3
|
|
ASX - By Stock
|
BRN |
Re:
2020 BRN Discussion
|
|
timmyjuly
|
29K |
13M |
5 |
21/09/20 |
21/09/20 |
ASX - By Stock
|
29K
|
13M
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Clinical trials.gov update
|
|
timmyjuly
|
44 |
29K |
26 |
19/09/20 |
19/09/20 |
ASX - By Stock
|
44
|
29K
|
26
|
|
ASX - By Stock
|
MSB |
Re:
Alliance for cell therapy now - Sep 16
|
|
timmyjuly
|
5 |
1.8K |
1 |
18/09/20 |
18/09/20 |
ASX - By Stock
|
5
|
1.8K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Alliance for cell therapy now - Sep 16
|
|
timmyjuly
|
5 |
1.8K |
0 |
18/09/20 |
18/09/20 |
ASX - By Stock
|
5
|
1.8K
|
0
|
|
ASX - By Stock
|
MSB |
Alliance for cell therapy now - Sep 16
|
|
timmyjuly
|
5 |
1.8K |
2 |
18/09/20 |
18/09/20 |
ASX - By Stock
|
5
|
1.8K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: DSMB Recommends Continuation of Phase 3 COVID-19 Trial
|
|
timmyjuly
|
299 |
138K |
4 |
04/09/20 |
04/09/20 |
ASX - By Stock
|
299
|
138K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ryoncil: ODAC/FDA Meeting Discussion
|
|
timmyjuly
|
2.0K |
681K |
5 |
14/08/20 |
14/08/20 |
ASX - By Stock
|
2.0K
|
681K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Clinical trials.gov update
|
|
timmyjuly
|
44 |
29K |
9 |
13/08/20 |
13/08/20 |
ASX - By Stock
|
44
|
29K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on Scheduled FDA Advisory Committee Meeting
|
|
timmyjuly
|
176 |
87K |
55 |
12/08/20 |
12/08/20 |
ASX - By Stock
|
176
|
87K
|
55
|
|
ASX - By Stock
|
MSB |
JCR further increasing Temcell manufacturing capacity
|
|
timmyjuly
|
4 |
2.5K |
21 |
04/08/20 |
04/08/20 |
ASX - By Stock
|
4
|
2.5K
|
21
|
|
ASX - By Stock
|
MSB |
Re:
Clinical trials.gov update
|
|
timmyjuly
|
44 |
29K |
22 |
31/07/20 |
31/07/20 |
ASX - By Stock
|
44
|
29K
|
22
|
|
ASX - By Stock
|
MSB |
Re:
ADCOM date for Ryoncil issued by FDA - aGVHD
|
|
timmyjuly
|
14 |
6.7K |
5 |
21/07/20 |
21/07/20 |
ASX - By Stock
|
14
|
6.7K
|
5
|
|
ASX - By Stock
|
MSB |
ADCOM date for Ryoncil issued by FDA - aGVHD
|
|
timmyjuly
|
14 |
6.7K |
61 |
21/07/20 |
21/07/20 |
ASX - By Stock
|
14
|
6.7K
|
61
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
timmyjuly
|
17K |
6.6M |
4 |
09/07/20 |
09/07/20 |
ASX - By Stock
|
17K
|
6.6M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Analysis of the EAP
|
|
timmyjuly
|
1.0K |
487K |
2 |
01/07/20 |
01/07/20 |
ASX - By Stock
|
1.0K
|
487K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Clinical trials.gov update
|
|
timmyjuly
|
44 |
29K |
48 |
20/06/20 |
20/06/20 |
ASX - By Stock
|
44
|
29K
|
48
|
|
ASX - By Stock
|
MSB Biotech |
Re:
MSB Trading - 2020
|
|
timmyjuly
|
23K |
13M |
8 |
29/05/20 |
29/05/20 |
ASX - By Stock
|
23K
|
13M
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Clinical trials.gov update
|
|
timmyjuly
|
44 |
29K |
20 |
17/05/20 |
17/05/20 |
ASX - By Stock
|
44
|
29K
|
20
|
|
ASX - By Stock
|
MSB |
Clinical trials.gov update
|
|
timmyjuly
|
44 |
29K |
24 |
14/05/20 |
14/05/20 |
ASX - By Stock
|
44
|
29K
|
24
|
|